Casandra
Casandra Test Code QD11015Version 1 (DRAFT)
Performing Lab
Recombx® MaTa Autoantibody Test
Also known as: Ma2, PNM1, Ma1, PNM2
Clinical Use
Order TestUse
Anti‑Ma and anti‑Ta antibodies can be detected in patients with a wide range of paraneoplastic neurological syndromes including acute or subacute onset of symptoms of limbic encephalitis, brainstem encephalitis, cerebellar degeneration, or polyneuropathy. This semi‑quantitative assay may be useful in monitoring therapeutic responses in select cases.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (Other)
Biomarkers
Ma
ProteinMa autoantibody • Other • Binary (Detected / Not Detected)
Ta
ProteinTa autoantibody • Other • Binary (Detected / Not Detected)
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
2 mL serum
Minimum Volume
0.5 mL
Collection Instructions
Serum must be separated from cells within 48 hours of collection.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 72 hours |
| Refrigerated | 28 days |
| Frozen | 28 days |
Related Tests
Other tests from different labs that may be relevant
Ma2/Ta Antibody, IgG by Immunoblot, Serum
ARUP Laboratories
Ma2/Ta Antibody, IgG by Immunoblot, CSF
ARUP Laboratories
Ma2 Antibody by ELISA, Serum
Mayo Clinic Lab
Ma2 Antibody, ELISA, Spinal Fluid
Mayo Clinic Lab
Paraneoplastic, Autoantibody Evaluation, Serum
Mayo Clinic Lab
Axonal Neuropathy, Autoimmune/Paraneoplastic Evaluation, Serum
Mayo Clinic Lab
Paraneoplastic, Autoantibody Profile
Labcorp
Autoimmune Neurology/Comprehensive Paraneoplastic Profile
Labcorp
Autoimmune Neurology/Comprehensive Paraneoplastic Profile, Spinal Fluid
Labcorp
Autoimmune Myelopathy Profile
Labcorp